Indeed, in a melanoma setting removal of TET2 from myeloid cells reverted their immune suppressive phenotype induced by IL-1 and allowed a type 1 polarization leading to the recruitment of T cells that could contrast tumor growth (130). Here, TET2 is linked to neoplasm.